MSCO annual meeting held on 2019-5-18

MSCO and Kiang Wu Hospital Oncology Image Seminar was held on 2019-5-18 at Macau. Attendance came form China mainland, HK, Taiwan and Macau. There were 4 sections in the seminar, focus on prostate cancer, breast cancer, lung cancer and lymphoma. In each section, speakers talks about recent progress in disease specific image characteristics, advance in treatment and diagnosis. This event held every 2 years in Macau.

Celebrating the first annul meeting of MSCO!

For the first time, MSCO brings together oncology professionals and research scientists from Macau, Hong Kong and Guangzhou to discuss state-of-the-art treatment modalities, new therapies, and ongoing controversies in the field.

Lung Cancer Symposium

Oncologists from Beijing, Shanghai, Hunan, and Fujian joined lung cancer symposium hosted by MSCO in Crown Plaza Hotel Macau.

Elaine’s group discovered a cardiac glycoside restrains EGFR-related and EGFR-independent NSCLC cell proliferation with distinct treatment mechanism

Non-small cell lung cancer (NSCLC) is the predominant histological type of lung cancer and is characterized by the highest mortality and incidence rates among these types of malignancies (1, 2). Traditional Chinese medicine (TCM) has been applied for centuries in China (3, 4). Cardiac glycosides, a class of natural products, have been identified as a potential type of chemotherapeutic agent (5, 6).